A recent study reveals that an American tobacco company threatened a pharmaceutical company, using its connections, to withdraw from distributing and selling a smoking cessation gum. The American Medical Association's weekly publication has printed a letter from Philip Morris tobacco company addressed to the pharmaceutical company Dow, in which Dow is threatened that if it markets its new smoking cessation gum featuring anti-smoking messages, the tobacco company will refrain from purchasing Dow's pesticides for tobacco farms. A subsequent letter indicates that shortly after, the anti-smoking messages were removed from the gum packaging. Researchers accuse Philip Morris of having used the same tactic in the early 1990s to pressure a Swiss pharmaceutical company into withholding its first shipment of smoking cessation patches.
A Tobacco Company Threatens to Halt Anti-Smoking Messages Printing
Philip Morris threatened Dow Pharmaceuticals to prevent the release of a smoking cessation gum with anti-smoking messages. This incident highlights the lengths tobacco companies will go to suppress anti-smoking initiatives. It raises concerns about corporate influence on public health messaging.
👥 Key Players
📰 What Happened
Philip Morris threatened Dow Pharmaceuticals to prevent the marketing of a smoking cessation gum that included anti-smoking messages. This led to the removal of those messages from the product packaging.
- Philip Morris used its purchasing power to influence Dow's marketing decisions.
- This tactic mirrors previous actions taken by Philip Morris in the 1990s against a Swiss pharmaceutical company.
💡 Why It Matters
📚 Background
Tobacco companies have a history of undermining public health initiatives to protect their profits, often using threats and pressure tactics against competitors and health organizations.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%